Back
Marker Therapeutics Stock Predictions
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
33
MRKR
Marker Therapeutics
Last Price:
3.50
Seasonality Move:
8.13%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Marker Therapeutics Stock Forecast
-
Is Marker Therapeutics Stock Undervalued?
The current Marker Therapeutics [MRKR] share price is $3.64. The Score for MRKR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal. - MRKR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Marker Therapeutics Stock Go Up Next Year?
Data Unavailable
Marker Therapeutics Stock Rating
Data Unavailable
Marker Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
http//www.markertherapeutics.com
52-Week Data
52-Week High:
6.16
52-Week Low:
2.44
Prediction Charts
Market Cap:
32.48M
Price in USD:
3.64
Volume:
23.11K
Beta:
3.31
Technical Analysis
SMA50:
3.27
SMA100:
3.87
SMA200:
4.04
52-Wk Change:
37.88%
Stock Predictions
-
Is Marker Therapeutics stock public?
Yes, Marker Therapeutics is a publicly traded company. -
What is the Marker Therapeutics stock quote today?
The Marker Therapeutics stock price is 3.64 USD today. -
How to buy Marker Therapeutics stock online?
You can buy Marker Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-25 | 4.00 | 4.33 | 4.45 | 4.00 |
| Oct-28 | 4.44 | 4.31 | 4.49 | 4.12 |
| Oct-29 | 4.29 | 4.14 | 4.46 | 4.06 |
| Oct-30 | 4.00 | 4.10 | 4.45 | 3.99 |
| Oct-31 | 4.06 | 3.97 | 4.30 | 3.95 |
| Nov-1 | 4.09 | 3.66 | 4.11 | 3.60 |
| Nov-4 | 3.72 | 3.52 | 3.77 | 3.52 |
| Nov-5 | 3.61 | 3.70 | 3.77 | 3.52 |
| Nov-6 | 3.84 | 4.05 | 4.25 | 3.63 |
| Nov-7 | 3.94 | 4.29 | 4.40 | 3.80 |
| Nov-8 | 4.35 | 4.14 | 4.39 | 4.00 |
| Nov-11 | 4.14 | 3.79 | 4.14 | 3.52 |
| Nov-12 | 3.60 | 3.72 | 3.75 | 3.60 |
| Nov-13 | 3.81 | 3.64 | 3.90 | 3.60 |
Marker Therapeutics Earnings
Data Unavailable
Marker Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.